General description
Levodopa + carbidopa is a combination of L-Dopa and a peripheral decarboxylase inhibitor used to treat Parkinson disease.
INN
Levodopa + carbidopa
ATC codes
Medicine type
Chemical agent
EML status history
First added in 1977
(TRS
615)
for
Parkinson disease
Wikipedia
Recommendations
Section
Medicines for parkinsonism
- Oral > Solid: 100 mg + 10 mg tablet; 250 mg + 25 mg tablet; 100 mg + 25 mg tablet
Indications